Literature DB >> 19666124

The pre-GAP-related domain of neurofibromin regulates cell migration through the LIM kinase/cofilin pathway.

Sigal Starinsky-Elbaz1, Lior Faigenbloom, Eitan Friedman, Reuven Stein, Yoel Kloog.   

Abstract

Neurofibromin contains several domains, most notably a GAP-related domain (GRD), that down-regulates Ras pathways. The functions of the non-GRD neurofibromin domains are largely known. Here we show that the pre-GRD region of neurofibromin alters the expression of genes involved in cell adhesion and migration and acts as a negative regulator of the Rac1/Pak1/LIMK1/cofilin pathway. Thus, neurofibromin-deficient glioblastoma and mouse fibroblasts are enriched in Rac1-GTP, p-Pak1, p-LIMK1 and p-cofilin, with all proteins exhibiting decreased expression upon expression of NF1(1-1163) polypeptide. Concomitantly, actin stress fibers and focal adhesion were disassembled and cell migration was halted. These effects were independent of the Ras signaling pathways. It seems that NF1(1-1163), through negative regulation of Rac-1, shifts the balance from a state of inactive phospho-cofilin to active unphosphorylated cofilin, resulting in severing of F-actin. Impairment of these cellular functions of neurofibromin provides novel insights into the invasiveness/progression of NF1-associated tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666124     DOI: 10.1016/j.mcn.2009.07.014

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  16 in total

1.  Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.

Authors:  Li Lai; Junchen Liu; Dong Zhai; Qingxiang Lin; Lijun He; Yanmin Dong; Jing Zhang; Binbin Lu; Yihua Chen; Zhengfang Yi; Mingyao Liu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  Heterotopic ossification has some nerve.

Authors:  Elizabeth Salisbury; Corinne Sonnet; Michael Heggeness; Alan R Davis; Elizabeth Olmsted-Davis
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

Review 3.  LIM Kinases, Promising but Reluctant Therapeutic Targets: Chemistry and Preclinical Validation In Vivo.

Authors:  Rayan Berabez; Sylvain Routier; Hélène Bénédetti; Karen Plé; Béatrice Vallée
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 4.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

5.  Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton.

Authors:  Efrat Mashiach-Farkash; Roni Rak; Galit Elad-Sfadia; Roni Haklai; Shmuel Carmeli; Yoel Kloog; Haim J Wolfson
Journal:  Oncotarget       Date:  2012-06

6.  Novel LIMK2 Inhibitor Blocks Panc-1 Tumor Growth in a mouse xenograft model.

Authors:  Roni Rak; Roni Haklai; Galit Elad-Tzfadia; Haim J Wolfson; Shmuel Carmeli; Yoel Kloog
Journal:  Oncoscience       Date:  2014-01-01

Review 7.  The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction.

Authors:  Olga Soriano; Marta Alcón-Pérez; Miguel Vicente-Manzanares; Esther Castellano
Journal:  Genes (Basel)       Date:  2021-05-27       Impact factor: 4.096

8.  The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells.

Authors:  Xiaochao Tan; Shan Wang; Bin Yang; Liyuan Zhu; Bin Yin; Tengfei Chao; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

9.  Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathways.

Authors:  Béatrice Vallée; Michel Doudeau; Fabienne Godin; Aurélie Gombault; Aurélie Tchalikian; Marie-Ludivine de Tauzia; Hélène Bénédetti
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.

Authors:  Jirko Kühnisch; Jong Seto; Claudia Lange; Susanne Schrof; Sabine Stumpp; Karolina Kobus; Julia Grohmann; Nadine Kossler; Peter Varga; Monika Osswald; Denise Emmerich; Sigrid Tinschert; Falk Thielemann; Georg Duda; Wenke Seifert; Thaqif El Khassawna; David A Stevenson; Florent Elefteriou; Uwe Kornak; Kay Raum; Peter Fratzl; Stefan Mundlos; Mateusz Kolanczyk
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.